Know Labs Bio-RFID Blood Glucose Monitor 2023 Technical Study

Know Labs presents technical feasibility data for Bio-RFID, a novel non-invasive electromagnetic platform for blood glucose monitoring. The study compared Bio-RFID predictions against Dexcom G6 readings across 92 samples from five participants, achieving 46% accuracy within FDA thresholds with a mean absolute relative difference of 20.6%. Results validate Bio-RFID as stable infrastructure for continuous glucose monitoring without the pain or recurring costs of traditional methods.